US Stock MarketDetailed Quotes

Senti Biosciences (SNTI)

Watchlist
  • 1.090
  • +0.080+7.92%
Close Apr 24 16:00 ET
  • 1.100
  • +0.010+0.92%
Post 19:54 ET
33.95MMarket Cap-0.40P/E (TTM)

Senti Biosciences (SNTI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
22K
22K
0
0
0
0
0
0
0
0
Operating revenue
--22K
--22K
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
4.98%63.75M
-14.18%13.61M
11.39%16.95M
25.77%16.8M
0.59%16.4M
-11.66%60.73M
-13.96%15.85M
-17.49%15.22M
-15.87%13.36M
1.88%16.3M
Selling and administrative expenses
-0.35%23.43M
-29.80%5.18M
-1.56%5.76M
74.23%6.08M
-5.63%6.42M
-32.57%23.51M
-14.01%7.38M
-30.71%5.85M
-60.55%3.49M
-24.54%6.8M
-General and administrative expense
-0.35%23.43M
-29.80%5.18M
-1.56%5.76M
74.23%6.08M
-5.63%6.42M
-32.57%23.51M
-14.01%7.38M
-30.71%5.85M
-60.55%3.49M
-24.54%6.8M
Research and development costs
9.40%37.59M
-0.15%7.76M
21.50%10.52M
9.59%10.03M
5.72%9.28M
6.86%34.36M
-14.80%7.77M
-4.81%8.66M
33.09%9.15M
24.37%8.78M
Depreciation amortization depletion
-4.37%2.74M
-5.39%667K
-5.18%677K
-3.63%690K
-3.18%701K
23.92%2.86M
-2.89%705K
-28.17%714K
76.35%716K
297.80%724K
-Depreciation and amortization
-4.37%2.74M
-5.39%667K
-5.18%677K
-3.63%690K
-3.18%701K
23.92%2.86M
-2.89%705K
-28.17%714K
76.35%716K
297.80%724K
Operating profit
-4.94%-63.73M
14.32%-13.58M
-11.39%-16.95M
-25.77%-16.8M
-0.59%-16.4M
9.05%-60.73M
13.96%-15.85M
16.33%-15.22M
12.06%-13.36M
-8.93%-16.3M
Net non-operating interest income expense
-2.22%927K
-57.83%97K
10.67%166K
14.41%270K
19.03%394K
-66.90%948K
-46.01%230K
-74.27%150K
-70.28%236K
-68.80%331K
Non-operating interest income
-2.22%927K
-57.83%97K
10.67%166K
14.41%270K
19.03%394K
-66.90%948K
-46.01%230K
-74.27%150K
-70.28%236K
-68.80%331K
Other net income (expense)
-80.51%1.36M
-106.53%-980K
90.26%-1.34M
-6.36%1.8M
-51.00%1.89M
135.83%6.99M
2,285.44%15.01M
27.41%-13.8M
1,231.25%1.92M
7,466.67%3.86M
Gain on sale of security
----
----
----
----
----
-421.34%-12.73M
--0
-366.65%-15.45M
--324K
--2.4M
Special income (charges)
-1,624.23%-5.05M
----
----
----
----
98.86%-293K
107.38%20K
98.78%-313K
--0
--0
-Less:Restructuring and merger&acquisition
--0
----
----
----
----
90.34%-20K
---20K
--0
--0
--0
-Less:Impairment of capital assets
1,514.06%5.05M
----
----
----
----
-98.79%313K
--0
-98.78%313K
----
----
Other non- operating income (expenses)
-67.94%6.41M
-73.40%4.07M
-181.65%-1.34M
12.68%1.8M
29.43%1.89M
773.62%20.01M
980.24%15.31M
85.99%1.65M
39,925.00%1.59M
18,362.50%1.46M
Income before tax
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
36.71%-52.79M
96.74%-610K
21.16%-28.87M
21.38%-11.2M
12.57%-12.11M
Income tax
Net income
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
Net income continuous Operations
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
36.71%-52.79M
96.74%-610K
21.16%-28.87M
21.38%-11.2M
12.57%-12.11M
Net income discontinuous operations
----
----
----
----
----
--0
--0
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
Basic earnings per share
77.31%-2.73
20.90%-0.53
89.06%-0.69
77.14%-0.56
46.79%-1.41
24.86%-12.03
84.01%-0.67
-87.80%-6.31
41.94%-2.45
36.90%-2.65
Diluted earnings per share
77.31%-2.73
20.90%-0.53
89.06%-0.69
77.14%-0.56
46.79%-1.41
24.86%-12.03
84.01%-0.67
-87.80%-6.31
41.94%-2.45
36.90%-2.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 22K22K00000000
Operating revenue --22K--22K--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 4.98%63.75M-14.18%13.61M11.39%16.95M25.77%16.8M0.59%16.4M-11.66%60.73M-13.96%15.85M-17.49%15.22M-15.87%13.36M1.88%16.3M
Selling and administrative expenses -0.35%23.43M-29.80%5.18M-1.56%5.76M74.23%6.08M-5.63%6.42M-32.57%23.51M-14.01%7.38M-30.71%5.85M-60.55%3.49M-24.54%6.8M
-General and administrative expense -0.35%23.43M-29.80%5.18M-1.56%5.76M74.23%6.08M-5.63%6.42M-32.57%23.51M-14.01%7.38M-30.71%5.85M-60.55%3.49M-24.54%6.8M
Research and development costs 9.40%37.59M-0.15%7.76M21.50%10.52M9.59%10.03M5.72%9.28M6.86%34.36M-14.80%7.77M-4.81%8.66M33.09%9.15M24.37%8.78M
Depreciation amortization depletion -4.37%2.74M-5.39%667K-5.18%677K-3.63%690K-3.18%701K23.92%2.86M-2.89%705K-28.17%714K76.35%716K297.80%724K
-Depreciation and amortization -4.37%2.74M-5.39%667K-5.18%677K-3.63%690K-3.18%701K23.92%2.86M-2.89%705K-28.17%714K76.35%716K297.80%724K
Operating profit -4.94%-63.73M14.32%-13.58M-11.39%-16.95M-25.77%-16.8M-0.59%-16.4M9.05%-60.73M13.96%-15.85M16.33%-15.22M12.06%-13.36M-8.93%-16.3M
Net non-operating interest income expense -2.22%927K-57.83%97K10.67%166K14.41%270K19.03%394K-66.90%948K-46.01%230K-74.27%150K-70.28%236K-68.80%331K
Non-operating interest income -2.22%927K-57.83%97K10.67%166K14.41%270K19.03%394K-66.90%948K-46.01%230K-74.27%150K-70.28%236K-68.80%331K
Other net income (expense) -80.51%1.36M-106.53%-980K90.26%-1.34M-6.36%1.8M-51.00%1.89M135.83%6.99M2,285.44%15.01M27.41%-13.8M1,231.25%1.92M7,466.67%3.86M
Gain on sale of security ---------------------421.34%-12.73M--0-366.65%-15.45M--324K--2.4M
Special income (charges) -1,624.23%-5.05M----------------98.86%-293K107.38%20K98.78%-313K--0--0
-Less:Restructuring and merger&acquisition --0----------------90.34%-20K---20K--0--0--0
-Less:Impairment of capital assets 1,514.06%5.05M-----------------98.79%313K--0-98.78%313K--------
Other non- operating income (expenses) -67.94%6.41M-73.40%4.07M-181.65%-1.34M12.68%1.8M29.43%1.89M773.62%20.01M980.24%15.31M85.99%1.65M39,925.00%1.59M18,362.50%1.46M
Income before tax -16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M36.71%-52.79M96.74%-610K21.16%-28.87M21.38%-11.2M12.57%-12.11M
Income tax
Net income -16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M
Net income continuous Operations -16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M36.71%-52.79M96.74%-610K21.16%-28.87M21.38%-11.2M12.57%-12.11M
Net income discontinuous operations ----------------------0--0--0--0--0
Minority interest income
Net income attributable to the parent company -16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M
Basic earnings per share 77.31%-2.7320.90%-0.5389.06%-0.6977.14%-0.5646.79%-1.4124.86%-12.0384.01%-0.67-87.80%-6.3141.94%-2.4536.90%-2.65
Diluted earnings per share 77.31%-2.7320.90%-0.5389.06%-0.6977.14%-0.5646.79%-1.4124.86%-12.0384.01%-0.67-87.80%-6.3141.94%-2.4536.90%-2.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More